Literature DB >> 15833319

Decavanadate effects in biological systems.

Manuel Aureliano1, Ricardo M C Gândara.   

Abstract

Vanadium biological studies often disregarded the formation of decameric vanadate species known to interact, in vitro, with high-affinity with many proteins such as myosin and sarcoplasmic reticulum calcium pump and also to inhibit these biochemical systems involved in energy transduction. Moreover, very few in vivo animal studies involving vanadium consider the contribution of decavanadate to vanadium biological effects. Recently, it has been shown that an acute exposure to decavanadate but not to other vanadate oligomers induced oxidative stress and a different fate in vanadium intracellular accumulation. Several markers of oxidative stress analyzed on hepatic and cardiac tissue were monitored after in vivo effect of an acute exposure (12, 24 h and 7 days), to a sub-lethal concentration (5 mM; 1 mg/kg) of two vanadium solutions ("metavanadate" and "decavanadate"). It was observed that "decavanadate" promote different effects than other vanadate oligomers in catalase activity, glutathione content, lipid peroxidation, mitochondrial superoxide anion production and vanadium accumulation, whereas both solutions seem to equally depress reactive oxygen species (ROS) production as well as total intracellular reducing power. Vanadium is accumulated in mitochondria in particular when "decavanadate" is administered. These recent findings, that are now summarized, point out the decameric vanadate species contributions to in vivo and in vitro effects induced by vanadium in biological systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833319     DOI: 10.1016/j.jinorgbio.2005.02.024

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  12 in total

1.  Neuroprotective effect of carnosine in the olfactory bulb after vanadium inhalation in a mouse model.

Authors:  Laura Colín-Barenque; Patricia Bizarro-Nevares; Adriana González Villalva; Jose Pedraza-Chaverri; Omar Noel Medina-Campos; Ruben Jimenez-Martínez; Daniela S Rodríguez-Rangel; Stefanie Reséndiz; Teresa I Fortoul
Journal:  Int J Exp Pathol       Date:  2018-09-09       Impact factor: 1.925

2.  Recent perspectives into biochemistry of decavanadate.

Authors:  Manuel Aureliano
Journal:  World J Biol Chem       Date:  2011-10-26

Review 3.  Vanadium in Biosphere and Its Role in Biological Processes.

Authors:  Deepika Tripathi; Veena Mani; Ravi Prakash Pal
Journal:  Biol Trace Elem Res       Date:  2018-03-09       Impact factor: 3.738

4.  Controlled drug delivery and cell adhesion for bone tissue regeneration by Keplerate polyoxometalate (Mo132)/metronidazole/PMMA scaffolds.

Authors:  Hamid Taghiyar; Bahram Yadollahi; Abolghasem Abbasi Kajani
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

5.  Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures.

Authors:  Tiago A S Brandão; Howard Robinson; Sean J Johnson; Alvan C Hengge
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

Review 6.  Spherical Oligo-Silicic Acid SOSA Disclosed as Possible Endogenous Digitalis-Like Factor.

Authors:  Franz Kerek; Victor A Voicu
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-23       Impact factor: 5.555

7.  Comparison of proton-specific ATPase activities in plume and root tissues of two co-occurring hydrocarbon seep tubeworm species Lamellibrachia luymesi and Seepiophila jonesi.

Authors:  Sharmishtha Dattagupta; Meredith Redding; Kathryn Luley; Charles Fisher
Journal:  Mar Biol       Date:  2009-01-31       Impact factor: 2.573

8.  Evidence That Speciation of Oxovanadium Complexes Does Not Solely Account for Inhibition of Leishmania Acid Phosphatases.

Authors:  Benjamin M Dorsey; Craig C McLauchlan; Marjorie A Jones
Journal:  Front Chem       Date:  2018-04-12       Impact factor: 5.221

9.  Pharmacological and Toxicological Threshold of Bisammonium Tetrakis 4-(N,N-Dimethylamino)pyridinium Decavanadate in a Rat Model of Metabolic Syndrome and Insulin Resistance.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Víctor Enrique Sarmiento-Ortega; José Ángel Flores-Hernández; Eduardo Brambila; Francisco J Meléndez; Enrique González-Vergara
Journal:  Bioinorg Chem Appl       Date:  2018-06-19       Impact factor: 7.778

10.  Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus.

Authors:  Samuel Treviño; Denisse Velázquez-Vázquez; Eduardo Sánchez-Lara; Alfonso Diaz-Fonseca; José Ángel Flores-Hernandez; Aarón Pérez-Benítez; Eduardo Brambila-Colombres; Enrique González-Vergara
Journal:  Oxid Med Cell Longev       Date:  2016-03-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.